StockData
Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc. (IOVA) stock

IOVANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3086% above fair value
$7.48−0.05 (-0.66%)

Close on Nov 18, 2026Market cap $3.39BP/E –Yield –

Iovance Biotherapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Iovance Biotherapeutics's total debt was $1.00M at Dec 31, 2024. For fiscal 2024 it was $1.00M, up 0.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$1.00M0.0%
FY2023Dec 31, 2023$1.00M0.0%
FY2022Dec 31, 2022$1.00M0.0%
FY2021Dec 31, 2021$1.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$1.00M0.0%
Q3 FY2024Sep 30, 2024$1.00M0.0%
Q2 FY2024Jun 30, 2024$1.00M0.0%
Q1 FY2024Mar 31, 2024$1.00M0.0%
Q4 FY2023Dec 31, 2023$1.00M0.0%
Q3 FY2023Sep 30, 2023$1.00M0.0%
Q2 FY2023Jun 30, 2023$1.00M0.0%
Q1 FY2023Mar 31, 2023$1.00M0.0%
Q4 FY2022Dec 31, 2022$1.00M0.0%
Q3 FY2022Sep 30, 2022$1.00M0.0%
Q2 FY2022Jun 30, 2022$1.00M0.0%
Q1 FY2022Mar 31, 2022$1.00M0.0%
Q4 FY2021Dec 31, 2021$1.00M–
Q3 FY2021Sep 30, 2021$1.00M–
Q2 FY2021Jun 30, 2021$1.00M–
Q1 FY2021Mar 31, 2021$1.00M–

More Iovance Biotherapeutics figures

See a number that looks wrong?